PharmAla Biotech Holdings, Inc. Financial Overview
PharmAla Biotech Holdings, Inc.'s market cap is currently C$10.57M. The company's EPS TTM is C$-0.005; its P/E ratio is ―; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on July 25, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
